Trial NCT04134468

View at ClinicalTrials.gov 
Org. Study IDs: UPCC10219
Secondary IDs: IRB833642

Last trial update was posted on 2020-01-31

MeSH Interventions

Albumin-Bound Paclitaxel Gemcitabine

MeSH Conditions

Adenocarcinoma

Other Conditions

Pancreatic Ductal Adenocarcinoma

Stopping Reasons

Halozyme halted development of PEGPH20 following Phase 3 failure.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID